Hepatitis C Drugs Market Global Forecast By Distribution Channels - Renub Research

According to Renub Research analysis Global Hepatitis C Drugs Market would be US$ 5.9 Billion by 2025. Forecast By Regions & Distribution Channels
 
ROSWELL, Ga. - May 30, 2020 - PRLog -- Hepatitis C is a viral infection that causes severe damage to the human body; it is an infection caused by a virus that damages the liver, which leads to inflammation. It spread through contaminated blood. The prevalence of hepatitis C infection among the global populace is escalating. This is mainly caused by sharing needles, unsterilized medical equipment, and a blood transfusion from infected mothers to newborn babies. As per Renub Research Analysis, the Global Hepatitis C drugs Market would be US$ 5.9 Billion by 2025.

In recent years, several drugs have been launched due to the high prevalence of Hepatitis C across the globe. Hepatitis C drug market is always developing, and competition is between new launches of fixed-dose combination led to a change in revenue of companies. The newly launched drug by AbbiVie i.e., Mavyret, has led to a downfall in the revenue of one of the market leader i.e. Gilead's. Mavyret has several advantages compared to other drugs such as its treatment course is shorter, and it is much cheaper. Harvoni drugs are popular in India, and it's easier affordable among the public.

Oral injections and dosages are required weekly in Hepatitis C; at the same time, its side effects can lead to permanent damage of other organs of patients. Around the globe, many clinical trials, as well as numerous successful drug clearances, give traction to this market. Apart from that, the rising number of regulatory approvals will further boost the market during the forecast time frame.

Hepatitis C drugs have witnessed numerous drug approvals likewise, in the year 2019, USFDA approves Mavyret for the treatment of pediatric hepatitis patients. For the treatment of all genotypes of Hepatitis C, Mavyret was the first treatment.

Follow the link for more information: https://www.renub.com/hepatitis-c-market-and-forecast-hep...

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com

Contact
Renub Research
***@renub.com
+1-678-302-0700
End
Email:***@renub.com Email Verified
Tags:Hepatitis C Drug Market
Industry:Manufacturing
Location:Roswell - Georgia - United States
Subject:Companies
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Renub Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share